Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03497091 · ClinicalTrials.gov registry record
Retrospective Review of Amino Acid Formula Use at a Children's Center
A clinical trial, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- 23
- Enrollment target
NCT03497091: Completed study, sponsored by Société des Produits Nestlé (SPN).
NCT03497091 is a clinical trial that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03497091 has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
This is a retrospective review of data documented in medical records.
Primary Outcome
Medical diagnosis
Interventions
- OTHER Enteral Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2018-06-15 |
| Est. Completion | 2019-01-31 |
What the finished NCT03497091 record still lists
NCT03497091 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Enteral Formula is the first listed.
NCT03497091 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03497091 about?
NCT03497091 is a clinical study titled "Retrospective Review of Amino Acid Formula Use at a Children's Center". This is a retrospective review of data documented in medical records.
What is the current status of trial NCT03497091?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2018-06-15. Estimated completion is 2019-01-31.
What interventions are being tested in trial NCT03497091?
The interventions under investigation include: Enteral Formula (OTHER).
Who is sponsoring clinical trial NCT03497091?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI